Ranibizumab Treat-and-Extend Regimen May Be Better for Neovascular AMD

A ranibizumab treat-and-extend regimen appears to be better than a pro re nata (PRN) regimen for treating neovascular age-related macular degeneration (AMD), according to researchers from Switzerland.
Reuters Health Information

Full Story →